Please leave this field empty
(800) 458-6223 info@curesearch.org
Select Page

CureSearch Announces Catapult Impact Fund Award

Posted: September 27, 2017

For Immediate Release
Contact:
Sarita Sastry, PhD
National Director, Research and Programs
(240) 235-2215 | sarita.sastry@curesearch.org

Up to $5 million will be awarded to promising, clinic-ready pediatric cancer research projects

Bethesda, Md. – CureSearch for Children’s Cancer announced the application launch for a $2 million to $5 million (USD) Catapult Impact Fund Award opportunity. The award will support the advancement of clinical research to improve outcomes for pediatric cancer patients.

CureSearch is currently soliciting proposals for its 2017-2018 Catapult Impact Fund Award cycle. Through these awards, CureSearch will provide support for projects that will advance promising therapies for pediatric cancer into or further along in clinical development and that show a strong potential for future approval and commercialization. Highest priority will be given to projects that address areas of highly urgent, unmet needs in pediatric cancer. Catapult Awards will fund support, as requested, up to $5 million for a timeframe of two-three years.

In order to qualify, Phase 1 and Phase 2 pediatric clinical trial projects must be “clinic-ready” and fit the following parameters:

  • Proposed trials to test novel, targeted agents or “repurposed” adult targeted agents for high-risk and relapsed pediatric cancers.
  • Pediatric clinical trials should be either IND-ready, available for clinical trial use under existing/active IND (or IND equivalent) or already have received FDA or regulatory approval for an adult indication, but not previously tested for pediatric oncology indications.
  • For “first in-human” clinical studies, all pre-clinical pharmacology and non-human safety and toxicology studies should be completed.
  • Collaborative projects, between academia and industry, may leverage existing regulatory guidelines or governmental programs that require or reward research in the development of new therapies for pediatric patients.

This grant opportunity is funded by CureSearch for Children’s Cancer to catapult better, less toxic children’s cancer treatments out of the laboratory and into the clinic with the ultimate goal of improving clinical outcomes in childhood cancer patients.

The application window opened Monday, September 18, 2017 via Proposal Central; award notifications will be released in February 2018. Funding provided for up to 3 years, depending on project. The Request for Application is available here.

For more information about this grant opportunity or pediatric cancer research sponsored by CureSearch for Children’s Cancer, contact Sarita Sastry, PhD, National Director, Research and Programs, +1 (240) 235-2215, sarita.sastry@curesearch.org.


###

CureSearch for Children’s Cancer

CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md., works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch is building a $10 million research pipeline to aggressively drive pediatric research grants and clinical trials that have a higher chance of becoming cures for children’s cancer without the toxic side effects that plague current treatment options.

For more information, visit curesearch.org or curesearchsuperheroes.org, follow CureSearch on Twitter @curesearch or join the conversation on Facebook at facebook.com/curesearch.

CureSearch Announces Catapult Impact Fund Award was last modified: September 27th, 2017 by Geoff Duncan

Let’s stay connected

Get our latest news and research updates delivered to your inbox.

  • This field is for validation purposes and should be left unchanged.
Menu

Pin It on Pinterest